| Date | Time | Source | Headline | Symbol | Company |
| 12/20/2006 | 9:00AM | PR Newswire (US) | A Washington Biotechnology & Biomedical Association Event | NASDAQ:GILD | Gilead Sciences Inc |
| 12/18/2006 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on GE, CSCO, GILD, AMT, and HTZ | NASDAQ:GILD | Gilead Sciences Inc |
| 12/11/2006 | 4:00PM | Business Wire | Gilead Grants Intellectual Property Rights for Tenofovir Topical Gel to the International Partnership for Microbicides and CONRA | NASDAQ:GILD | Gilead Sciences Inc |
| 12/07/2006 | 7:55PM | Business Wire | Gilead Sciences Receives Subpoena from U.S. Department of Justice | NASDAQ:GILD | Gilead Sciences Inc |
| 12/05/2006 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on YHOO, PEP, GILD, SGP, and KR | NASDAQ:GILD | Gilead Sciences Inc |
| 12/01/2006 | 4:30PM | Business Wire | Gilead Sciences to Present at the NASDAQ 18th Investor Program on Thursday, December 7 | NASDAQ:GILD | Gilead Sciences Inc |
| 11/22/2006 | 4:30PM | Business Wire | Gilead Sciences to Present at Two Upcoming Investor Conferences | NASDAQ:GILD | Gilead Sciences Inc |
| 11/15/2006 | 11:31AM | PR Newswire (US) | Seven Summits Research Releases Comments on BRCM, AMZN, GILD, LUV, and NSC | NASDAQ:GILD | Gilead Sciences Inc |
| 11/14/2006 | 4:30PM | Business Wire | Gilead Sciences to Present at the Credit Suisse Healthcare Conference on Friday, November 17th | NASDAQ:GILD | Gilead Sciences Inc |
| 11/14/2006 | 8:30AM | Business Wire | Gilead Sciences Successfully Completes Tender Offer for Shares of Myogen With Over 91.3 Percent of Shares Tendered | NASDAQ:GILD | Gilead Sciences Inc |
| 11/03/2006 | 4:00PM | Business Wire | Gilead Sciences Completes Acquisition of Raylo Chemicals Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 11/01/2006 | 6:27PM | Business Wire | Gilead Sciences Extends Expiration Date for Tender Offer for Myogen Until November 13, 2006 | NASDAQ:GILD | Gilead Sciences Inc |
| 10/26/2006 | 4:00PM | Business Wire | Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period | NASDAQ:GILD | Gilead Sciences Inc |
| 10/18/2006 | 4:00PM | Business Wire | Gilead Sciences Announces Third Quarter 2006 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 10/13/2006 | 4:30PM | Business Wire | Gilead Sciences to Release Third Quarter 2006 Financial Results on Wednesday, October 18, 2006 | NASDAQ:GILD | Gilead Sciences Inc |
| 10/09/2006 | 3:30AM | PR Newswire (US) | Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA(TM) (efavirenz 600 | NASDAQ:GILD | Gilead Sciences Inc |
| 09/29/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on DELL, GILD, SII, ACN, and BOBJ | NASDAQ:GILD | Gilead Sciences Inc |
| 09/28/2006 | 8:50PM | PR Newswire (US) | Bristol-Myers Squibb and Gilead Sciences Establish Agreement to Commercialize ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 m | NASDAQ:GILD | Gilead Sciences Inc |
| 09/27/2006 | 8:30AM | Business Wire | Landmark Five-Year Data on Gilead's Anti-HIV Drug Viread(R) Presented at 8th International Workshop on Adverse Drug Reactions an | NASDAQ:GILD | Gilead Sciences Inc |
| 09/22/2006 | 4:00PM | Business Wire | Gilead Announces Licensing Agreements with Eight India-Based Companies for Manufacturing and Distribution of Generic Versions Of | NASDAQ:GILD | Gilead Sciences Inc |
| 09/21/2006 | 4:15PM | Business Wire | Gilead Sciences to Present at The UBS Global Life Sciences Conference on Monday, September 25th; Webcast Available Through Gilea | NASDAQ:GILD | Gilead Sciences Inc |
| 09/18/2006 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on JPM, RIG, PEP, GILD, and CCL | NASDAQ:GILD | Gilead Sciences Inc |
| 09/08/2006 | 4:15PM | Business Wire | Gilead Sciences to Present at the Bear Stearns 19th Annual Healthcare Conference on Tuesday, September 12th; Webcast Available T | NASDAQ:GILD | Gilead Sciences Inc |
| 09/01/2006 | 4:15PM | Business Wire | Gilead Sciences to Present at Two Upcoming Investor Conferences | NASDAQ:GILD | Gilead Sciences Inc |
| 08/30/2006 | 4:15PM | Business Wire | Gilead Sciences' President and Chief Executive Officer Establishes Rule 10b5-1 Stock Trading Plan | NASDAQ:GILD | Gilead Sciences Inc |
| 08/14/2006 | 4:15PM | Business Wire | Gilead Announces Licensing Agreements with Three India-Based Companies for Manufacturing and Distribution of Generic Versions o | NASDAQ:GILD | Gilead Sciences Inc |
| 08/14/2006 | 9:00AM | Business Wire | 96-Week Data from Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both in Combination with Sustiva(R) Pres | NASDAQ:GILD | Gilead Sciences Inc |
| 08/11/2006 | 4:15PM | Business Wire | Gilead Sciences Completes Acquisition of Corus Pharma | NASDAQ:GILD | Gilead Sciences Inc |
| 08/10/2006 | 12:37PM | PR Newswire (US) | Seven Summits Research Releases Comments on GE, DISH, GLW, GILD, and QLGC | NASDAQ:GILD | Gilead Sciences Inc |
| 08/02/2006 | 4:00PM | Business Wire | Gilead Sciences Exercises Option to Acquire Corus Pharma for $365 Million | NASDAQ:GILD | Gilead Sciences Inc |